In no way am I trying to down-ramp, or bring doubt to what will likely be a significant event for Imugene...However, has anyone else had the following thought...
If the onCARlytics (CF33-CD19t oncolytic virus) results are so significant and 'paradigm shifting' - why are they just a abstract/poster readout? Wouldn't they warrant their own presentation/session/seminar?
There are some 850+ poster presentations - are we saying that Abstract #368 is more significant than the results that are actually being 'presented' and formally delivered? If so, why is it given the same time as the other abstracts - or is it a mandate for preclinical/trial results to be abstracts only?
Apologies in advance if what I have stated/asked is ignorant - I've never been to any sort of health/medical conference!
Outstanding news, page-27
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.001(0.75%) |
Mkt cap ! $490.4M | |||
| Open | High | Low | Value | Volume |
| 6.8¢ | 6.8¢ | 6.7¢ | $35.99K | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1452558 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 490207 | 8 |
View Market Depth
| Last trade - 10.21am 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
0.001 ( 1.34 %) |
||||
| Open | High | Low | Volume | ||
| 6.8¢ | 6.9¢ | 6.7¢ | 504589 | ||
| Last updated 10.39am 31/05/2024 ? | |||||
| IMU (ASX) Chart |